Compare DexCom, Inc. (DXCM) vs Simon Property Group Inc (SPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Simon Property Group Inc — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while Simon Property Group Inc trades at $199.42 (market cap $64.59B). The key difference: Simon Property Group Inc is far larger — about 2× DexCom, Inc.'s market cap, and Simon Property Group Inc pays a 4.46% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Simon Property Group Inc for 99 Days on average.
| DXCM | SPG | |
|---|---|---|
Market Cap | $31.86B | $64.59B |
Volume | 3,607,070 | 1,093,907 |
Sector | Health | Real Estate |
52-Week High | $92.34 | $236.70 |
52-Week Low | $54.84 | $173.35 |
Typical Hold Time | 62 Days | 99 Days |
Enterprise Value | $31.32B | $93.03B |
Dividend Yield | — | 4.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth from $2.9B in 2022 to $4.66B in 2025. Profit margins have expanded significantly to 17.93%, while analyst sentiment remains overwhelmingly positive with 81% buy ratings. Recent news highlights the company's focus on Type 2 diabetes market expansion and leadership appointments.
DXCM presents a compelling growth story with expanding profitability and market opportunities, though elevated valuation multiples and technical bearish signals warrant caution. The consensus price target of $95.07 suggests 13% upside potential, but investors should monitor competitive pressures and reimbursement challenges in the CGM market.
SPG trades at $199.61, up 1.02% today, amid a bearish technical signal with support at $198 and resistance at $201. The company reported strong 2025 results with net income of $4.63B and a net margin of 72.7%, though Q2 2026 EPS missed expectations. Recent news highlights strong leasing demand and the launch of Simon Media Network to monetize mall traffic.
Outlook is mixed: analyst consensus is a Buy with a $221.27 target, but technicals are bearish. Investment opportunity lies in solid fundamentals and a 4%+ dividend yield, while risks include rising bond yields, high debt levels, and potential redemption of preferred shares.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →
